ANDA 87003, held by Hikma. Acetaminophen; Oxycodone Hydrochloride.
As of Nov 15, 2026, ANDA 87003 (Roxicet), held by Hikma, was first approved by FDA on Feb 25, 1980, with 32 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 25, 1980 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Roxicet325MG;5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet;oral | Acetaminophen; Oxycodone Hydrochloride | DiscontinuedReference drug |
| Jun 18, 2026 | Supplement 52REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 50Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 48REMS | Approved | None posted |
| Mar 7, 2024 | Supplement 47Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 46Labeling · Standard review | Approved | None posted |
| Mar 4, 2021 | Supplement 45Labeling · Standard review | Approved | None posted |
| Oct 8, 2019 | Supplement 43Labeling · Standard review | Approved | None posted |
| Sep 21, 2018 | Supplement 42Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 41REMS | Approved | None posted |
| Dec 16, 2016 | Supplement 39Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 38Labeling · Standard review | Approved | None posted |
| Aug 12, 2014 | Supplement 36Labeling · Standard review | Approved | None posted |
| Oct 18, 2013 | Supplement 35Labeling · Standard review | Approved | None posted |
| Jun 28, 2011 | Supplement 34Labeling | Approved | None posted |
| Aug 29, 2007 | Supplement 27Labeling | Approved | None posted |
| Jun 5, 2001 | Supplement 20Labeling | Approved | None posted |
| Mar 22, 1999 | Supplement 19Manufacturing | Approved | None posted |
| Aug 28, 1996 | Supplement 18Manufacturing | Approved | None posted |
| Jun 19, 1995 | Supplement 17Manufacturing | Approved | None posted |
| Sep 15, 1994 | Supplement 14Manufacturing | Approved | None posted |
| Sep 23, 1993 | Supplement 16Labeling | Approved | None posted |
| May 13, 1993 | Supplement 15Labeling | Approved | None posted |
| May 29, 1991 | Supplement 13Labeling | Approved | None posted |
| Feb 1, 1991 | Supplement 8Manufacturing | Approved | None posted |
| Feb 1, 1991 | Supplement 7Labeling | Approved | None posted |
| Feb 1, 1991 | Supplement 6Manufacturing | Approved | None posted |
| Aug 29, 1989 | Supplement 9Labeling | Approved | None posted |
| Oct 21, 1988 | Supplement 12Manufacturing | Approved | None posted |
| Oct 21, 1988 | Supplement 11Manufacturing | Approved | None posted |
| Oct 21, 1988 | Supplement 10Manufacturing | Approved | None posted |
| Sep 1, 1982 | Supplement 1Manufacturing | Approved | None posted |
| Mar 29, 1982 | Supplement 2Manufacturing | Approved | None posted |
| Feb 25, 1980 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters